Ultrasound in Obstetrics and Gynecology
By Jiri Sonek, January 17, 2021. M.U. is a 32-year-old G2 P1 Caucasian female, who presented at 13 weeks’ gestation by LMP for first trimester combined screening. [Read More...]
By Jiri Sonek, January 17, 2021. M.U. is a 32-year-old G2 P1 Caucasian female, who presented at 13 weeks’ gestation by LMP for first trimester combined screening. [Read More...]
April 1, 2019. BioFluidica presented at the AACR Conference in Atlanta, GA, April 2019 the following abstracts, "A Non-invasive Diagnostics to Detect Circulating Leukemic Cells in Blood. [Read More...]
MedTech Insight | Bob Kronemyer, March 12, 2019 San Diego, California-based BioFluidica Inc. developed the Liquid Scan microfluidic chip that can both monitor and detect circulating tumor [Read More...]
March 10, 2019 BioFluidica presented at the Molecular Med Tri-Conference in San Francisco, CA, March 2019 the following abstracts, "Detection of CTCs from Whole Blood of Lung [Read More...]
The University of Kansas Cancer Center, January 20, 2019 Tune in February 20, 2019 as KU Cancer Center director Roy Jensen, MD, will host Steven Soper, PhD, KU [Read More...]
genomeweb | By John Gilmore, January 17, 2019 NEW YORK (GenomeWeb) – Fresh off being awarded several grants by the National Institutes of Health, startup BioFluidica has [Read More...]
PR Newswire, January 10, 2019 SAN DIEGO /PRNewswire/ -- BioFluidica, a privately held cancer diagnostics company, has been awarded an SBIR Phase II National Institutes of Health grant [Read More...]
PR Newswire, January 07, 2019 SAN DIEGO /PRNewswire/ -- BioFluidica, a privately held cancer diagnostics company, has been awarded two separate SBIR Phase I NIH grants, the first [Read More...]